Cargando…

Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound

Malignant cells display an increased sensitivity towards drugs that reduce the function of the ubiquitin-proteasome system (UPS), which is the primary proteolytic system for destruction of aberrant proteins. Here, we report on the discovery of the bioactivatable compound CBK77, which causes an irrev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giovannucci, Tatiana A., Salomons, Florian A., Haraldsson, Martin, Elfman, Lotta H. M., Wickström, Malin, Young, Patrick, Lundbäck, Thomas, Eirich, Jürgen, Altun, Mikael, Jafari, Rozbeh, Gustavsson, Anna-Lena, Johnsen, John Inge, Dantuma, Nico P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494907/ https://www.ncbi.nlm.nih.gov/pubmed/34615851 http://dx.doi.org/10.1038/s41419-021-04191-9

Ejemplares similares

Identification of a novel compound that simultaneously impairs the ubiquitin-proteasome system and autophagy
por: Giovannucci, Tatiana A., et al.
Publicado: (2021)

Reporter-Based Screens for the Ubiquitin/Proteasome System
por: Gierisch, Maria E., et al.
Publicado: (2020)

A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling
por: Dantuma, Nico P., et al.
Publicado: (2006)

Cytosolic stress granules relieve the ubiquitin‐proteasome system in the nuclear compartment
por: Xu, Shanshan, et al.
Publicado: (2022)

Ubiquitin versus misfolding: The minimal requirements for inclusion body formation
por: Dantuma, Nico P., et al.
Publicado: (2016)

The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution
por: Dantuma, Nico P., et al.
Publicado: (2014)

Ubiquitin crosstalk connecting cellular processes
por: Groothuis, Tom AM, et al.
Publicado: (2006)

Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
por: Tümmler, Conny, et al.
Publicado: (2017)

Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation
por: Lindsten, Kristina, et al.
Publicado: (2002)

Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo
por: Punganuru, Surendra Reddy, et al.
Publicado: (2018)

NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016)

The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complex
por: Bott, Laura C., et al.
Publicado: (2016)

Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
por: Johnsen, John Inge, et al.
Publicado: (2019)

Real Estate in the DNA Damage Response: Ubiquitin and SUMO Ligases Home in on DNA Double-Strand Breaks
por: Dantuma, Nico P., et al.
Publicado: (2016)

CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
por: Almqvist, Helena, et al.
Publicado: (2016)

Detection of ubiquitin–proteasome enzymatic activities in cells: Application of activity-based probes to inhibitor development()
por: Kramer, Holger B., et al.
Publicado: (2012)

GIT1 protects against breast cancer growth through negative regulation of Notch
por: Zhang, Songbai, et al.
Publicado: (2022)

C-terminal UBA domains protect ubiquitin receptors by preventing initiation of protein degradation
por: Heinen, Christian, et al.
Publicado: (2011)

Cdc48-independent proteasomal degradation coincides with a reduced need for ubiquitylation
por: Gödderz, Daniela, et al.
Publicado: (2015)

Yeast Ribonucleotide Reductase Is a Direct Target of the Proteasome and Provides Hyper Resistance to the Carcinogen 4-NQO
por: Spasskaya, Daria S., et al.
Publicado: (2023)

The ubiquitin-proteasome pathway in cancer.
por: Spataro, V., et al.
Publicado: (1998)

The ubiquitin proteasome system in neuropathology
por: Lehman, Norman L.
Publicado: (2009)

The recognition of ubiquitinated proteins by the proteasome
por: Grice, Guinevere L., et al.
Publicado: (2016)

Ataxin‐3 consolidates the MDC1‐dependent DNA double‐strand break response by counteracting the SUMO‐targeted ubiquitin ligase RNF4
por: Pfeiffer, Annika, et al.
Publicado: (2017)

JNK–NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress
por: Kostecka, A, et al.
Publicado: (2014)

The Ubiquitin Conjugating Enzyme: An Important Ubiquitin Transfer Platform in Ubiquitin-Proteasome System
por: Liu, Weigang, et al.
Publicado: (2020)

Poxvirus Exploitation of the Ubiquitin-Proteasome System
por: Barry, Michele, et al.
Publicado: (2010)

The Ubiquitin-Proteasome Pathway in Huntington's Disease
por: Mitra, Siddhartha, et al.
Publicado: (2008)

Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
por: Ernst, Robert, et al.
Publicado: (2011)

The ubiquitin-proteasome system in Alzheimer's disease
por: Oddo, Salvatore
Publicado: (2008)

Autoregulation of the 26S proteasome by in situ ubiquitination
por: Jacobson, Andrew D., et al.
Publicado: (2014)

Ubiquitin Proteasome System in Stress and Disease
por: Karpov, Dmitry, et al.
Publicado: (2012)

Intracellular Dynamics of the Ubiquitin-Proteasome-System
por: Chowdhury, Maisha, et al.
Publicado: (2015)

Ubiquitin-Proteasome System in Neurodegenerative Disorders
por: Rao, Geeta, et al.
Publicado: (2015)

The Ubiquitin–Proteasome System in Immune Cells
por: Çetin, Gonca, et al.
Publicado: (2021)

Ubiquitin-proteasome system in diabetic retinopathy
por: Svikle, Zane, et al.
Publicado: (2022)

Copper homeostasis and the ubiquitin proteasome system
por: Zhang, Bichao, et al.
Publicado: (2023)

The Ubiquitin–Proteasome System in Tumor Metabolism
por: Wang, Jie, et al.
Publicado: (2023)

Correction to: JNK–NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress
por: Kostecka, A., et al.
Publicado: (2018)

The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
por: Orlowski, Robert Z, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ns1mmej81419q5973fhhh1pkla